Ad
FATE Short Information Fate Therapeutics Inc.
home / stock / fate / fate short
Short Information | Fate Therapeutics Inc. (NASDAQ:FATE)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 7,230,753 |
| Total Actual Volume | 40,508,200 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 361,538 |
| Average Short Percentage | 17.96% |
Is there a FATE Short Squeeze or Breakout about to happen?
See the FATE Short Analysis for free Sign up or Login
Powered by Squeeze Report
FATE Twenty Trading Day's Volume to Short Volume Chart
FATE Twenty Trading Day Price Chart
FATE Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 06-20-2025 | $1.26 | $1.19 | $1.28 | $1.16 | 1,996,286 | 285,848 | 14.32% |
| 06-18-2025 | $1.19 | $1.21 | $1.32 | $1.16 | 1,855,975 | 229,890 | 12.39% |
| 06-17-2025 | $1.24 | $1.2 | $1.31 | $1.19 | 1,519,089 | 254,951 | 16.78% |
| 06-16-2025 | $1.29 | $1.24 | $1.33 | $1.2126 | 1,495,197 | 288,125 | 19.27% |
| 06-13-2025 | $1.4 | $1.275 | $1.4 | $1.27 | 2,429,143 | 664,146 | 27.34% |
| 06-12-2025 | $1.5 | $1.4 | $1.5064 | $1.39 | 2,173,356 | 430,133 | 19.79% |
| 06-11-2025 | $1.72 | $1.55 | $1.74 | $1.5201 | 4,034,960 | 823,649 | 20.41% |
| 06-10-2025 | $1.55 | $1.67 | $1.82 | $1.535 | 4,935,474 | 1,059,533 | 21.47% |
| 06-09-2025 | $1.66 | $1.52 | $1.66 | $1.485 | 1,422,083 | 235,917 | 16.59% |
| 06-06-2025 | $1.36 | $1.6 | $1.68 | $1.36 | 4,680,675 | 488,435 | 10.44% |
| 06-05-2025 | $1.41 | $1.34 | $1.425 | $1.34 | 799,850 | 82,133 | 10.27% |
| 06-04-2025 | $1.36 | $1.42 | $1.45 | $1.35 | 1,898,118 | 179,479 | 9.46% |
| 06-03-2025 | $1.3 | $1.36 | $1.41 | $1.24 | 1,834,222 | 296,541 | 16.17% |
| 06-02-2025 | $1.29 | $1.3 | $1.39 | $1.26 | 1,774,372 | 316,525 | 17.84% |
| 05-30-2025 | $1.31 | $1.21 | $1.325 | $1.21 | 1,332,995 | 429,180 | 32.2% |
| 05-29-2025 | $1.27 | $1.32 | $1.38 | $1.27 | 1,424,554 | 352,659 | 24.76% |
| 05-28-2025 | $1.21 | $1.27 | $1.35 | $1.19 | 1,747,853 | 276,621 | 15.83% |
| 05-27-2025 | $1.19 | $1.22 | $1.295 | $1.19 | 1,403,848 | 163,678 | 11.66% |
| 05-23-2025 | $1.16 | $1.16 | $1.21 | $1.15 | 788,583 | 150,309 | 19.06% |
| 05-22-2025 | $1.15 | $1.2 | $1.22 | $1.14 | 961,567 | 223,001 | 23.19% |
News, Short Squeeze, Breakout and More Instantly...
Fate Therapeutics Inc. Company Name:
FATE Stock Symbol:
NASDAQ Market:
-4.13% G/L:
$1.19 Last:
1,996,286 Volume:
$1.26 Open:
$1.19 Close:
Fate Therapeutics Inc. Website:
Ad
-
All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR); first patient to reach 1-year follow-up continues in drug-free Definition of Remission in SLE (DORIS) First extrarenal SLE patie...
-
SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to patients, today announced the appointment of Ma...
-
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to patients, today announced that c...